Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NIO Inc. (NIO) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

NIO Inc. vs uniQure N.V. Ordinary Shares — how do they compare? NIO Inc. trades at $3.38 (market cap $8.54B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: NIO Inc. is far larger — about 5.8× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

NIOQURE
Market Cap
$8.54B$1.48B
Volume
34,684,9032,488,780
Sector
Consumer CyclicalHealth
52-Week High
$7.42$70.59
52-Week Low
$3.37$9.03
Typical Hold Time
81 Days0 Days
Enterprise Value
$6.43B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NIO Inc.

NIO trades at $3.41, down 1.73% on the day and near its 52-week low, reflecting a bearish technical trend. The company reported a net loss of $15.57 billion in 2025, though revenue grew to $87.49 billion and the net loss margin improved to -17.8%. Recent news highlights a strategic battery-swapping partnership with Geely, which could expand NIO's network but has weighed on the stock as investors assess profitability ahead of Q3 2026 earnings.

The outlook remains challenging due to persistent losses and intense EV competition, but analyst consensus is a Buy with a $6.23 price target, suggesting significant upside. Key risks include high debt, cash burn, and price wars in China's EV market, while opportunities lie in scaling the battery-swap network and potential margin improvement if delivery growth continues.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NIO
23% Buy77% Sell
Avg holding period · 81 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About NIO Inc.

NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.

Read more on NIO →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →